Odd Bta Fta Status

Category
Continent
From
To
 
Ouro Medicines Takes Bold Step with OM336

Ouro Medicines Takes Bold Step with OM336

Category : ODD/BTA/FTA Status 6 August 2025

Biotech startup Ouro Medicines has launched a multi-national clinical trial for OM336, a bispecific...
Shanton Pharma’s SAP-001 Receives FDA Fast Track D...

Shanton Pharma’s SAP-001 Receives FDA Fast Track D...

Category : ODD/BTA/FTA Status 28 July 2025

Shanton Pharma, a clinical-stage biotech company focused on novel therapies for gout, has announced...
FDA Grants Orphan Drug Status to Sanofi's Rilzabru...

FDA Grants Orphan Drug Status to Sanofi's Rilzabru...

Category : ODD/BTA/FTA Status 5 June 2025

The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, a no...
FDA Grants Breakthrough Status to Tinlarebant for...

FDA Grants Breakthrough Status to Tinlarebant for...

Category : ODD/BTA/FTA Status 24 May 2025

Belite Bio, Inc., a clinical-stage biopharmaceutical company focused on treating degenerative retina...
Alterity’s ATH434 Gets FDA Fast Track for Multiple...

Alterity’s ATH434 Gets FDA Fast Track for Multiple...

Category : ODD/BTA/FTA Status 6 May 2025

Alterity Therapeutics has been granted Fast Track designation by the U.S. Food and Drug Administrati...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!